|
Designated Public Office Holders who participated in the communication:
|
Ritu Banerjee,
Assistant Deputy Minister
Director General's Office,
Innovation, Science and Economic Development Canada (ISED)
|
| |
List of Details
|
Subject matter
|
Detail
|
|
Health,
Research and Development
|
Canada's Access to Medicines Regime with respect to ensuring that the program allows for the delivery of timely access to needed medicines to the developing world supported by a business climate in Canada that continues to encourage research into further treatment and prevention of disease.
|
|
Health,
Research and Development
|
Federal Government involvement in national strategies to address major chronic diseases having a significant burden on the Canadian health care system, such as Dementia, Diabetes, Hepatitis C and Cancer and major public health concerns such as Antimicrobial resistant.
|
|
| |
|
Responsible Officer who filed this communication report:
|
David D. Jones
|
| |
|
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
|
| |
